These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

557 related items for PubMed ID: 6435870

  • 1. Dopamine receptors: effects of chronic L-dopa and bromocriptine treatment in an animal model of Parkinson's disease.
    Schneider MB, Murrin LC, Pfeiffer RF, Deupree JD.
    Clin Neuropharmacol; 1984; 7(3):247-57. PubMed ID: 6435870
    [Abstract] [Full Text] [Related]

  • 2. Dopaminergic functional supersensitivity: effects of chronic L-dopa and carbidopa treatment in an animal model of Parkinson's disease.
    Hossain MA, Weiner N.
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1105-11. PubMed ID: 8263772
    [Abstract] [Full Text] [Related]

  • 3. Dopamine receptor changes in response to prolonged treatment with L-dopa.
    Groppetti A, Flauto C, Parati E, Vescovi A, Rusconi L, Parenti M.
    J Neural Transm Suppl; 1986 Dec; 22():33-45. PubMed ID: 2946813
    [Abstract] [Full Text] [Related]

  • 4. Effect of repeated L-DOPA, bromocriptine, or lisuride administration on preproenkephalin-A and preproenkephalin-B mRNA levels in the striatum of the 6-hydroxydopamine-lesioned rat.
    Henry B, Crossman AR, Brotchie JM.
    Exp Neurol; 1999 Feb; 155(2):204-20. PubMed ID: 10072296
    [Abstract] [Full Text] [Related]

  • 5. L-DOPA-induced dopamine efflux in the striatum and the substantia nigra in a rat model of Parkinson's disease: temporal and quantitative relationship to the expression of dyskinesia.
    Lindgren HS, Andersson DR, Lagerkvist S, Nissbrandt H, Cenci MA.
    J Neurochem; 2010 Mar; 112(6):1465-76. PubMed ID: 20050978
    [Abstract] [Full Text] [Related]

  • 6. Neuroprotective and neurotrophic effect of apomorphine in the striatal 6-OHDA-lesion rat model of Parkinson's disease.
    Yuan H, Sarre S, Ebinger G, Michotte Y.
    Brain Res; 2004 Nov 05; 1026(1):95-107. PubMed ID: 15476701
    [Abstract] [Full Text] [Related]

  • 7. Impact of the lesion procedure on the profiles of motor impairment and molecular responsiveness to L-DOPA in the 6-hydroxydopamine mouse model of Parkinson's disease.
    Francardo V, Recchia A, Popovic N, Andersson D, Nissbrandt H, Cenci MA.
    Neurobiol Dis; 2011 Jun 05; 42(3):327-40. PubMed ID: 21310234
    [Abstract] [Full Text] [Related]

  • 8. Bromocriptine holiday: effects on dopamine receptors and turning behavior in rats.
    Kenny AM, Schneider MB, Baden DR, Pfeiffer RF, Murrin LC.
    Neurology; 1986 Mar 05; 36(3):400-4. PubMed ID: 3081831
    [Abstract] [Full Text] [Related]

  • 9. Role of opiates in striatal D-1 dopamine receptor supersensitivity induced by chronic L-dopa treatment.
    Groppetti A, Ceresoli G, Mandelli V, Parenti M.
    J Pharmacol Exp Ther; 1990 Jun 05; 253(3):950-6. PubMed ID: 2162953
    [Abstract] [Full Text] [Related]

  • 10. Serotonergic activation after 2-week intrastriatal infusion of L-dopa and slow recovery of circling in rats with unilateral nigral lesions.
    Kääriäinen TM, García-Horsman JA, Piltonen M, Huotari M, Männistö PT.
    Basic Clin Pharmacol Toxicol; 2008 Mar 05; 102(3):300-7. PubMed ID: 17973898
    [Abstract] [Full Text] [Related]

  • 11. Characterization of enhanced behavioral responses to L-DOPA following repeated administration in the 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
    Henry B, Crossman AR, Brotchie JM.
    Exp Neurol; 1998 Jun 05; 151(2):334-42. PubMed ID: 9628768
    [Abstract] [Full Text] [Related]

  • 12. The differential effects of 5-HT(1A) receptor stimulation on dopamine receptor-mediated abnormal involuntary movements and rotations in the primed hemiparkinsonian rat.
    Dupre KB, Eskow KL, Negron G, Bishop C.
    Brain Res; 2007 Jul 16; 1158():135-43. PubMed ID: 17553470
    [Abstract] [Full Text] [Related]

  • 13. Substantia nigra 6-hydroxydopamine lesions alter dopaminergic synaptic markers in the nucleus basalis magnocellularis and striatum of rats.
    Geula C, Slevin JT.
    Synapse; 1989 Jul 16; 4(3):248-53. PubMed ID: 2532792
    [Abstract] [Full Text] [Related]

  • 14. Dopamine denervation does not alter in vivo 3H-spiperone binding in rat striatum: implications for external imaging of dopamine receptors in Parkinson's disease.
    Bennett JP, Wooten GF.
    Ann Neurol; 1986 Apr 16; 19(4):378-83. PubMed ID: 3707090
    [Abstract] [Full Text] [Related]

  • 15. Increased slow oscillatory activity in substantia nigra pars reticulata triggers abnormal involuntary movements in the 6-OHDA-lesioned rat in the presence of excessive extracellular striatal dopamine.
    Meissner W, Ravenscroft P, Reese R, Harnack D, Morgenstern R, Kupsch A, Klitgaard H, Bioulac B, Gross CE, Bezard E, Boraud T.
    Neurobiol Dis; 2006 Jun 16; 22(3):586-98. PubMed ID: 16531050
    [Abstract] [Full Text] [Related]

  • 16. Effects of L-Dopa on circadian rhythms of 6-OHDA striatal lesioned rats: a radiotelemetric study.
    Boulamery A, Simon N, Vidal J, Bruguerolle B.
    Chronobiol Int; 2010 Jan 16; 27(2):251-64. PubMed ID: 20370468
    [Abstract] [Full Text] [Related]

  • 17. Microdialysis study of the effects of the antiparkinsonian drug budipine on L-DOPA-induced release of dopamine and 5-hydroxytryptamine by rat substantia nigra and corpus striatum.
    Biggs CS, Starr MS.
    Synapse; 1999 Oct 16; 34(1):36-46. PubMed ID: 10459170
    [Abstract] [Full Text] [Related]

  • 18. Histological, behavioural and neurochemical evaluation of medial forebrain bundle and striatal 6-OHDA lesions as rat models of Parkinson's disease.
    Yuan H, Sarre S, Ebinger G, Michotte Y.
    J Neurosci Methods; 2005 May 15; 144(1):35-45. PubMed ID: 15848237
    [Abstract] [Full Text] [Related]

  • 19. The ability of grafted human sympathetic neurons to synthesize and store dopamine: a potential mechanism for the clinical effect of sympathetic neuron autografts in patients with Parkinson's disease.
    Nakao N, Shintani-Mizushima A, Kakishita K, Itakura T.
    Exp Neurol; 2004 Jul 15; 188(1):65-73. PubMed ID: 15191803
    [Abstract] [Full Text] [Related]

  • 20. Effects of iptakalim on extracellular glutamate and dopamine levels in the striatum of unilateral 6-hydroxydopamine-lesioned rats: a microdialysis study.
    Yang J, Hu LF, Liu X, Zhou F, Ding JH, Hu G.
    Life Sci; 2006 Mar 20; 78(17):1940-4. PubMed ID: 16216278
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.